U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX22095576: GSM7842498: MII oocyte 40 Mutant scRNAseq; Mus musculus; RNA-Seq
1 ILLUMINA (NextSeq 550) run: 4.2M spots, 640M bases, 276.5Mb downloads

External Id: GSM7842498_r1
Submitted by: Riccio, DiStABiF, University of Campania "Luigi Vanvitelli"
Study: A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes as well as failure of epigenetic reprogramming and zygotic genome activation in embryos [scRNA-seq]
show Abstracthide Abstract
Maternal inactivation of genes encoding components of the sub-cortical maternal complex (SCMC) and its associated member PADI6 generally results in early embryo lethality. In humans, SCMC gene variants were found in the healthy mothers of children affected by multi-locus imprinting disturbances (MLID). However, how the SCMC controls the DNA methylation required to regulate imprinting remains poorly defined. We generated a mouse line carrying a Padi6 missense variant that was identified in a family with Beckwith-Wiedemann syndrome and MLID. If homozygous in female mice this variant resulted in interruption of embryo development at the 2-cell stage. Single-cell multi-omic analyses demonstrated defective maturation of Padi6-mutant oocytes and incomplete DNA demethylation, down-regulation of zygotic genome activation (ZGA) genes, up-regulation of maternal decay genes and developmental delay in 2-cell embryos developing from Padi6-mutant oocytes, but little effect on genomic imprinting. Western blotting and immunofluorescence analyses showed reduced level of UHRF1 in oocytes and abnormal localization of DNMT1 and UHRF1 in both oocytes and zygotes. Treatment with 5-azacytidine reverted DNA hypermethylation but did not rescue the developmental arrest of mutant embryos. Taken together, this study demonstrates that PADI6 controls both nuclear and cytoplasmic oocyte processes that are necessary for pre-implantation epigenetic reprogramming and ZGA. Overall design: scRNA-seq and scBS-seq were perfomed on MII oocytes and 2cell embryo from new mutant mouse line carrying human variant of PADI6 gene. We sequenced 44 MII oocytes, 44 2cell embryo and 8 Negative control.
Sample: MII oocyte 40 Mutant scRNAseq
SAMN37821853 • SRS19161461 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM7842498
Instrument: NextSeq 550
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC SINGLE CELL
Selection: cDNA
Layout: PAIRED
Construction protocol: MII oocytes and 2-cell embryos were collected as described before. For 2-cell embryos, the zona pellucida was removed with Tyrode's solution (SIGMA-ALDRICH), the blastomeres were separated and the polar body was discarded. Then single oocytes and blastomeres were picked and put into a lysis buffer (Buffer RLT Plus Qiagen). DNA and RNA from lysate were separated using the G&T protocol (Angermueller et al. 2016). The magnetic beads (MyOne C1, Life Technologies) were washed and then annealed to oligo dTs. These were used to capture polyadenylated mRNA from individual cell lysate. The supernatant containing the DNA was transferred to a new tube and the beads washed three times in 1xFSS buffer (Superscript II, Invitrogen), 10 mM DTT, 0.005% Tween-20 (Sigma) and 0.4 U/μl of RNAsin (Promega) to remove all DNA residue. Each washing solution was added to the DNA tube to maximise recovery. mRNA on the beads was processed further for cDNA conversion. This involved the resuspension in 10 μl of reverse transcriptase mastermix (100 U SuperScript II (Invitrogen), 10 U RNAsin (Promega), 1 × Superscript II First-Strand Buffer, 5 mM DTT (Invitrogen), 1 M betaine (Sigma), 9 mM MgCl2 (Invitrogen), 1 μM Template-Switching Oligo (TSO, Eurogentec), 1 mM dNTP mix (Roche). The mRNA mixture was reverse transcribed by incubation for 60 min at 42 °C followed by 30 min at 50 °C and 10 min at 60 °C. The cDNA obtained was subjected to PCR amplification by adding 11 μl of 2x KAPA HiFi HotStart ReadyMix and 1 μl of ISPCR primer (2 μM). The amplification was carried out in a thermocycler at 98 °C for 3 min, followed by 15 cycles of 98 °C for 15 s, 67 °C for 20 s, 72 °C for 6 min and the final extension step at 72 °C for 5 min. The amplified product was purified using Ampure XP beads with a 1:1 ratio and eluted into 20 μl of water. Libraries were prepared from 100 to 400 pg of cDNA using the Nextera XT Kit (Illumina), per the manufacturer's instructions but with one-fifth volumes. All 96 single-cell RNA-seq libraries were pooled together and sequenced on the Illumina NextSeq platform to an average depth of 4.2 million reads, using paired-end 75 bp read-length settings.
Runs: 1 run, 4.2M spots, 640M bases, 276.5Mb
Run# of Spots# of BasesSizePublished
SRR263896924,210,212640M276.5Mb2023-10-18

ID:
30027397

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...